Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/XEPASONE TABLET 5 MG

Approved

THERAPEUTIC

XEPASONE TABLET 5 MG

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)🇸🇬 Health Sciences Authority

Approval Date: Apr 17, 1990
Approval ID: 73494ce90f401727
Company: XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type: Therapeutic

Approval Details

Approval Id: 73494ce90f401727
Drug Name: XEPASONE TABLET 5 MG
Product Name: XEPASONE TABLET 5 MG
Approval Number: SIN04190P
Approval Date: 1990-04-17
Registrant: APEX PHARMA MARKETING PTE. LTD.
Licence Holder: APEX PHARMA MARKETING PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: H02AB06
Atc Item Name: prednisolone
Pharma Manufacturer Name: APEX PHARMA MARKETING PTE. LTD.

Active Ingredients

PREDNISOLONE

5 mg

PREDNISOLONE

5 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Apr 17, 1990

Approval ID

73494ce90f401727

Type

Therapeutic

Back to HSA Approvals

XEPASONE TABLET 5 MG - HSA Drug Approval Details